| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-12 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-07 |